Meluzín Jaroslav, Janousek Stanislav, Mayer Jirí, Groch Ladislav, Hornácek Ivan, Hlinomaz Ota, Kala Petr, Panovský Roman, Prásek Jirí, Kamínek Milan, Stanícek Jaroslav, Klabusay Martin, Korístek Zdenek, Navrátil Milan, Dusek Ladislav, Vinklárková Jaroslava
1st Department of Internal Medicine/Cardioangiology, St Anna Hosp, MU Czech Republic.
Int J Cardiol. 2008 Aug 18;128(2):185-92. doi: 10.1016/j.ijcard.2007.04.098. Epub 2007 Aug 30.
There are only few data on long-term effectiveness of the stem cell therapy.
We studied the time course of global and regional left ventricular function in patients with acute myocardial infarction within 1 year after the autologous mononuclear bone marrow cell transplantation.
Sixty patients with a first acute myocardial infarction, who had been randomized into 3 groups, completed a 12-month protocol. Two groups were intracoronarily given bone marrow cells in either higher (10(8) cells, HD group, n=20) or lower (10(7) cells, LD group, n=20) doses. Twenty patients without cell transplantation served as a control (C) group. Doppler tissue imaging and the gated technetium-99m sestamibi single photon emission computed tomography were performed before cell transplantation and at 3, 6, and 12 months later.
The baseline peak systolic velocities of longitudinal contraction of the infarcted wall (S(infarct)) of 5.2 cm/s, 4.6 cm/s, and 4.4 cm/s in C, LD, and HD groups increased by 0.0 cm/s, 0.3 cm/s (p=NS vs. C group), and by 0.7 cm/s (p<0.05 vs. C group), respectively, at 3 months. At 12 months, however, the corresponding changes from baseline values of 0.1 cm/s, 0.2 cm/s, and 0.6 cm/s did not differ significantly (all p=NS). In contrast, the post-transplant improvements in the left ventricular ejection fraction by 6%, 7%, and 7% at months 3, 6, and 12, respectively, were preserved in HD group patients during the whole 12-month follow-up and remained significantly better as compared to controls.
In our study, the autologous mononuclear bone marrow cell transplantation provided sustained improvement in global left ventricular systolic function in patients with acute myocardial infarction. However, when evaluating regional systolic function of the infarcted wall, the short-term benefit was partially lost during the 12-month follow-up.
关于干细胞治疗的长期有效性的数据很少。
我们研究了自体单核骨髓细胞移植后1年内急性心肌梗死患者左心室整体和局部功能随时间的变化过程。
60例首次发生急性心肌梗死的患者被随机分为3组,完成了一项为期12个月的方案。两组分别经冠状动脉给予较高剂量(10⁸个细胞,HD组,n = 20)或较低剂量(10⁷个细胞,LD组,n = 20)的骨髓细胞。20例未进行细胞移植的患者作为对照组(C组)。在细胞移植前以及移植后3、6和12个月进行多普勒组织成像和门控锝-99m甲氧基异丁基异腈单光子发射计算机断层扫描。
C组、LD组和HD组梗死壁纵向收缩的基线峰值收缩速度(S梗死)分别为5.2 cm/s、4.6 cm/s和4.4 cm/s,在3个月时分别增加了0.0 cm/s、0.3 cm/s(与C组相比,p =无统计学意义)和0.7 cm/s(与C组相比,p < 0.05)。然而,在12个月时,与基线值相比相应的变化分别为0.1 cm/s、0.2 cm/s和0.6 cm/s,差异无统计学意义(所有p =无统计学意义)。相比之下,HD组患者在整个12个月的随访期间,移植后3、6和12个月左心室射血分数分别提高了6%、7%和7%,与对照组相比仍显著更好。
在我们的研究中,自体单核骨髓细胞移植使急性心肌梗死患者的左心室整体收缩功能持续改善。然而,在评估梗死壁的局部收缩功能时,在12个月的随访期间短期获益部分丧失。